Home/Pipeline/FreeHold Duo Retractor

FreeHold Duo Retractor

Direct organ/tissue retraction (e.g., gallbladder, colon, bladder) in laparoscopic/robotic surgery

CommercialActive

Key Facts

Indication
Direct organ/tissue retraction (e.g., gallbladder, colon, bladder) in laparoscopic/robotic surgery
Phase
Commercial
Status
Active
Company

About Freehold Surgical

FreeHold Surgical is a private medical device company developing a novel class of intracorporeal, adjustable retractors for minimally invasive abdominal and pelvic surgeries. Its core innovation lies in devices that are deployed through standard 5mm trocars, provide hands-free and continuously adjustable retraction, and eliminate the need for an assistant or dedicated extra port. The technology targets key limitations in laparoscopic and robotic surgery by improving surgeon autonomy and visualization while potentially reducing incision-related complications compared to existing retraction methods like the Nathanson retractor. The company appears to be in the commercial stage with FDA-registered products, targeting early revenue generation.

View full company profile